Highlights in myeloproliferative neoplasms from the 2016 American Society of Hematology meeting: Commentary

Clin Adv Hematol Oncol. 2017 Feb;15 Suppl 2(2):21-23.
No abstract available

Publication types

  • Congress

MeSH terms

  • Humans
  • Myeloproliferative Disorders / diagnosis*
  • Myeloproliferative Disorders / drug therapy*
  • Myeloproliferative Disorders / etiology
  • Myeloproliferative Disorders / mortality